Overall Fundamental outlook

Business Operations:

Sector: Basic Materials
Industry: Specialty Chemicals

Clean Science and Technology Limited, research, develops, manufactures, and markets specialty chemicals in India and internationally. The company operates through Performance Chemicals, FMCG Chemicals, and Pharma & Agro Intermediates segments. It also offers FMCG Chemicals, including anisole, guaiacol, 4-methoxy acetophenone, butylated hydroxy anisole, veratrole, L-ascorbyl palmitate, tertiary butyl hydroquinone, ortho methoxy toluene, and para di-methoxy benzene (1,4-DMB). In addition, the company offers performance chemicals comprising clean light stab 770, 4-hydroxy tempo, mono methyl ether of hydroquinone, butylated hydroxy anisole, L-ascorbyl palmitate, 2,5-di-tertiary butyl hydroquinone, tertiary butyl hydroquinone, and dimethyl sebacate. Further, it provides pharma and agro intermediates, such as dicyclohexylcarbodimide, veratrole, para benzoquinone, and para di-methoxy benzene (1,4-DMB). Clean Science and Technology Limited serves food and infant food formulations, agricultural chemicals, polymers and monomers, perfumes, cosmetic, and other sectors. The company was incorporated in 2003 and is based in Pune, India.

Revenue projections:

Revenue projections for CLEAN
Revenue projections for CLEAN

With Clean Science and Technology Limited's revenue expected to be lower than the previous year, investors may become cautious. Declining revenues often negatively impact the bottom line, reducing profitability and raising concerns among investors about the company's ability to maintain strong financial performance moving forward.

Financial Ratios:

currentRatio 5.136000
forwardPE 36.269093
debtToEquity 0.150000
earningsGrowth 0.055000
revenueGrowth 0.159000
grossMargins 0.637190
operatingMargins 0.331240
trailingEps 24.870000
forwardEps 35.090000

CLEAN's current ratio of 5.136 shows that the company has ample resources to service its short-term debt. This indicates a solid financial position, as CLEAN can rely on its cash reserves and current assets to cover its immediate liabilities without strain.
Clean Science and Technology Limited's positive gross and operating margins reflect its profitability and efficiency. These metrics demonstrate the company's ability to manage costs effectively while generating strong revenue, highlighting its solid financial health and operational effectiveness.
Clean Science and Technology Limited's forward EPS surpassing its trailing EPS signals projected growth in profitability, with the company expected to perform better this year. This forecast suggests that Clean Science and Technology Limited's earnings will improve compared to the previous financial year, highlighting optimism in its financial outlook.

Price projections:

Price projections for CLEAN
Price projections for CLEAN

Price projections for CLEAN have been revised downward over time, signaling decreasing optimism about the company's outlook. Analysts appear to be adjusting their expectations as concerns about future performance grow.

Insider Transactions:

Insider Transactions for CLEAN
Insider Transactions for CLEAN


There were 1 transactions selling CLEAN stock, with prevailing market price of 1329.3499755859375.No sell transactions took place in the period under consideration.With more buying than selling around Clean Science and Technology Limited's current price, investors could be expressing optimism. This trend may suggest that the market expects favorable outcomes for the stock, leading to an increased demand at these levels.

Recommendation changes over time:

Recommendations trend for CLEAN
Recommendations trend for CLEAN


Recent analysis shows a strong buy bias for CLEAN, encouraging investors to view it as a solid investment option. The positive sentiment surrounding CLEAN suggests it could be an attractive place to allocate funds, motivating potential investors to consider the stock as a valuable part of their portfolio.